We've spotted 1 possible red flag for DexCom you should be aware of. NasdaqGS:DXCM Earnings Per Share Growth as at Apr 2025 Uncover the next big thing with financially sound penny stocks that ...

DexCom (NasdaqGS:DXCM) recently experienced a 14% price increase over the past week. This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose ...

DXCM secures FDA clearance for its G7 15-Day CGM, the longest-lasting and most accurate wearable, enhancing user convenience ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of $107.00. The company’s shares closed la ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom ( DXCM – Research Report) yesterday and set a price target of $98.00. The company’s shares closed yesterday at $67.39. Filter, ...

Stock futures dipped on Thursday as investors weighed President Trump’s 90-day tariff reprieve for select countries, which ...

Fintel reports that on April 10, 2025, Mizuho initiated coverage of DexCom (NasdaqGS:DXCM) with a Outperform recommendation. Analyst Price Forecast Suggests 57.82% Upside As of April 1, 2025, the ...

In its fourth quarter 2024 investor letter, Sands Capital Select Growth Fund emphasized stocks such as DexCom, Inc. (NASDAQ:DXCM). DexCom, Inc. (NASDAQ:DXCM) is a medical device company that develops ...

Abbott's growth potential with GLP-1 tailwinds, robust FCF, and dividend growth. Read more on how ABT navigates tariffs while ...

In early trading on Thursday, shares of DexCom (DXCM) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 6.9%. Year to date, DexCom has lost about 8.1% of ...